CRA Insights

The rise of drug prices: What will US payers do next?

April 24, 2015

.sub-header{display:none;}
Lev Gerlovin, Ezra Josephson | Life Sciences
–>
Lev Gerlovin explores the future of payer response to rising drug prices and discuss strategies that manufacturers may consider to gain a competitive edge in this evolving landscape.

Related Capabilities

Meet the authors